{
    "organizations": [],
    "uuid": "e4d0df02864c31cfe8371e2a3fd1b228a7932f41",
    "author": "",
    "url": "https://www.reuters.com/article/brief-foundation-medicine-q1-loss-per-sh/brief-foundation-medicine-q1-loss-per-share-1-02-idUSASC09Z34",
    "ord_in_thread": 0,
    "title": "BRIEF-Foundation Medicine Q1 Loss Per Share $1.02",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Foundation Medicine Q1 Loss Per Share $1.02 Reuters Staff\n* FOUNDATION MEDICINE ANNOUNCES 2018 FIRST QUARTER RESULTS AND RECENT HIGHLIGHTS * SEES FY 2018 REVENUE $200 MILLION TO $220 MILLION\n* Q1 REVENUE $52.8 MILLION VERSUS I/B/E/S VIEW $44.9 MILLION\n* Q1 EARNINGS PER SHARE VIEW $-1.10 â€” THOMSON REUTERS I/B/E/S\n* EXPECTS 2018 REVENUE WILL BE IN RANGE OF $200 MILLION TO $220 MILLION\n* EXPECTS TO DELIVER BETWEEN 90,000 AND 100,000 CLINICAL TESTS IN 2018\n* EXPECTS OPERATING EXPENSES WILL BE IN RANGE OF $250 MILLION TO $260 MILLION IN 2018 ",
    "published": "2018-05-02T23:17:00.000+03:00",
    "crawled": "2018-05-02T23:36:48.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "foundation",
        "medicine",
        "q1",
        "loss",
        "per",
        "share",
        "reuters",
        "staff",
        "foundation",
        "medicine",
        "announces",
        "first",
        "quarter",
        "result",
        "recent",
        "highlight",
        "see",
        "fy",
        "revenue",
        "million",
        "million",
        "q1",
        "revenue",
        "million",
        "versus",
        "view",
        "million",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "expects",
        "revenue",
        "range",
        "million",
        "million",
        "expects",
        "deliver",
        "clinical",
        "test",
        "expects",
        "operating",
        "expense",
        "range",
        "million",
        "million"
    ]
}